Antithrombotic Effects due to Pharmacological Modulation of Thrombin-Activatable Fibrinolysis Inhibitor in Rats

Publisher： Karger

E-ISSN： 1423-0313|82|4|304-309

ISSN： 0031-7012

Source： Pharmacology, Vol.82, Iss.4, 2008-10, pp. : 304-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of the Calcium Release Inhibitor Dantrolene and the Ca2+-ATPase Inhibitor Thapsigargin on Spinal Nociception in Rats

By  

Pharmacology, Vol. 62, Iss. 3, 2001-03 ,pp. : 145-150

Karger

Access to resources Recommend Favorite

Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats

By  

Pharmacology, Vol. 85, Iss. 6, 2010-06 ,pp. : 350-356

Karger

Access to resources Recommend Favorite

Effects of Proton Pump Inhibitor Administration and Intake of a Combination of Yogurt and Galactooligosaccharides on Bone and Mineral Metabolism in Rats

By Takasugi Satoshi   Shioyama Miho   Kitade Masami   Nagata Masashi   Yamaji Taketo  

Nutrients, Vol. 8, Iss. 10, 2016-10 ,pp. : 653-653

MDPI

Access to resources Recommend Favorite

New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

By Esteve-Pastor María Asunción   Hernández-Romero Diana   Valdés Mariano   Marín Francisco  

Molecules, Vol. 21, Iss. 3, 2016-02 ,pp. : 284-284

MDPI

Access to resources Recommend Favorite

Effects of Silodosin, an α1A-Adrenoceptor Antagonist, and Distigmine, an Acetylcholinesterase Inhibitor, and Their Combined Effects on Impaired Voiding Function in Zucker Diabetic Fatty Rats

By  

Pharmacology, Vol. 95, Iss. 5-6, 2015-05 ,pp. : 285-292

Karger

Access to resources Recommend Favorite